Intersect ENT, Inc. Company Profile
Intersect ENT Inc., located in Palo Alto, Calif., is an innovator in local drug delivery focused on advancing clinically proven therapy solutions that improve quality of life for ear, nose and throat patients. The companyâs initial focus is a dissolvable steroid-releasing implant to treat patients with chronic sinusitis, a common condition that affects one out of seven adults in the U.S. and greatly impacts quality of life. The company holds fifteen issued U.S. patents and more than 70 patents and pending applications worldwide. Intersect ENT is backed by Kleiner, Perkins, Caufield & Byers; U.S. Venture Partners; PTV Sciences; and Medtronic. For more information please visit www.intersectENT.com.
News Articles
Intersect Follows Leaders In ENT
Following the lead of ENT start-ups like Acclarent and Entellus Medical, Intersect ENT Inc. is introducing a line of stent like implants capable of performing the same role drug-eluting stents played...
Intersect ENT in Series D financing for $30 million
Intersect ENT has completed the initial closing of a $30 million Series D round of financing. The financing round was led by new investor Norwest Venture Partners and drew participation from all of In...
Mini sinus implant from Intersect gains FDA approval
The FDA has granted Intersect ENT approval for its Propel mini implant, a second-generation, smaller version of its steroid-e -More-
Intersect ENT Inc. (Menlo Park, Calif.) raised $30 million in the initial close of a series D round led by new investor Norwest Venture Partners. All of the company's existing investors participated,...
Series D brings in $30mm for [Intersect ENT]
Ear, nose, and throat device developer [Intersect ENT Inc.] has raised $30mm through its Series D venture round. New backer Norwest Venture Partners led and was joined by all of the company’s curren...
Intersect ENT Grabs $30M for Drug/Device Combo for the Sinuses
If you utter the phrase “drug/device combo” inside the life sciences industry, most people will think you’re talking about products for cardiovascular disease, diabetes, or maybe neurological di...
Drugs and Medications
None
PubMed Articles
Generation of Singlet Oxygen during Photosensitized One-Electron Oxidation of DNA.
Crosstalk?! It is demonstrated that singlet oxygen molecules ((1) O(2) ) are produced during the reaction between superoxide and the guanine radical cation; this suggests that the parallel type I an...
Intersection of autophagy with pathways of antigen presentation.
Traditionally, macroautophagy (autophagy) is viewed as a pathway of cell survival. Autophagy ensures the elimination of damaged or unwanted cytosolic components and provides a source of cellular nutri...
Auxin 2012: a rich mea ho'oulu.
In December 2012, scientists from around the world gathered in Waikoloa, Hawaii for 'Auxin 2012', a meeting organized by Paula McSteen (University of Missouri, USA), Ben Scheres (Utrecht University, T...
Perioperative pharmacology: pharmacotherapeutics, pharmacokinetics, and pharmacodynamics.
Results of current research into perioperative medication errors have revealed that more than half of medication errors occur during the administration phase of the medication-use process. The adminis...
Biomarkers intersect with the exposome.
The exposome concept promotes use of omic tools for discovering biomarkers of exposure and biomarkers of disease in studies of diseased and healthy populations. A two-stage scheme is presented for pro...
Clinical Trials
None
Companies
Intersect ENT Inc. (www.IntersectENT.com) is a medical device company that is pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients....
Intersect ENT Inc., located in Palo Alto, Calif., is an innovator in local drug delivery focused on advancing clinically proven therapy solutions that improve quality of life for...
More Information about "Intersect ENT, Inc." on BioPortfolio
We have published hundreds of Intersect ENT, Inc. news stories on BioPortfolio along with dozens of Intersect ENT, Inc. Clinical Trials and PubMed Articles about Intersect ENT, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intersect ENT, Inc. Companies in our database. You can also find out about relevant Intersect ENT, Inc. Drugs and Medications on this site too.
